Cargando…
Liraglutide-Induced Pancreatitis: A Case Report and Literature Review
Liraglutide is an anti-diabetic medication used for the treatment of type 2 diabetes mellitus, obesity, and chronic weight management. It is a glucagon-like peptide-1 (GLP-1) agonist that helps reduce postprandial hyperglycemia for up to 24 h after administration. It stimulates endogenous insulin se...
Autores principales: | Javed, Hamna, Kogilathota Jagirdhar, Gowthami Sai, Kashyap, Rahul, Vekaria, Pratikkumar H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225244/ https://www.ncbi.nlm.nih.gov/pubmed/37252522 http://dx.doi.org/10.7759/cureus.38263 |
Ejemplares similares
-
Non-clostridium difficile induced pseudomembranous colitis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023) -
Heart failure in general and cardiac transplant patients with COVID-19
por: Sharma, Munish, et al.
Publicado: (2022) -
Suspected Gastroparesis With Concurrent Gastroesophageal Reflux Disease Induced by Low-Dose Liraglutide
por: Ishihara, Yo, et al.
Publicado: (2022) -
Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature
por: Kogilathota Jagirdhar, Gowthami Sai, et al.
Publicado: (2023) -
Relamorelin in Gastroparesis and Diabetic Gastroparesis: A Meta-Analysis on Its Efficacy and Safety
por: Patel, Akash, et al.
Publicado: (2023)